We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Veterinary Products Committee and the Veterinary Medicines Directorate will hold their annual open meeting on Friday 29 September 2017.
Scheme that provides assurance to the public and professional keepers of animals when buying medicines online.
Veterinary Medicines Directorate Pharmaceutical Industry Event presentation to attendees on 23 June 2017.
Details of the European Commission decision to withdraw the marketing authorisations of veterinary medicines containing zinc oxide for food producing species.
First DNA vaccine authorised in the EU to protect Atlantic salmon against Salmon Pancreas Disease.
Information event for the pharmaceutical industry on Friday 23 June 2017.
Web services, such as the Special Imports System, will be unavailable due to essential IT maintenance on the Bank Holiday weekend to 31 May 2017.
A summary of results from surveillance work carried out by the VMD's pharmacovigilance team concerning reported adverse events.
Details of VMD review of the approved active substances on the exemption for small pet animals list which may be marketed for use as anaesthetics in fish.
We are now on Twitter and Facebook.
Web services, such as the Special Imports System, will be unavailable due to essential maintenance from 7am to 3pm on Saturday 25th March.
The EMA Veterinary Committee has reached a final conclusion that the benefit:risk balance for veterinary medicines containing zinc oxide is negative.
Change of distribution category from POM-V to POM-VPS
The EMA Veterinary Committee has concluded that the benefit:risk balance for veterinary medicines containing zinc oxide is negative and that this class of products should be withdrawn.
Link to VMD survey
Following consultation the product literature standard (PLS) for mock-ups for an animal medicine licence has been updated.
VMD re-certified to international standards for quality management (ISO 9001) and information security management (ISO 27001).
Key points from the 2016 biannual pharmaceutical industry customer survey results and action plan.
This highlights report provides details of how the Veterinary Medicines Directorate (VMD) performed in the Civil Service People Survey.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).